Gossamer Bio Inc Investor Day Transcript
Good day, and thank you for standing by, and welcome to the Gossamer Bio CNS-penetrant BTK Investor Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Faheem Hasnain. Please go ahead.
Thank you, operator. Hello, and welcome, everyone, to Gossamer's CNS-Penetrant BTK Investor Day. We appreciate everyone for joining us today. I'd like to draw your attention to the obligatory forward-looking statements. And as a reminder, if you have to leave us early or if you'd like to revisit anything we say here today, a recording will be available on our website at gossamerbio.com as well as a copy of the presentation we're walking through today.
So before we go any further, I'd like to introduce the Gossamer team that you'll be hearing from today. I am Faheem Hasnain, Co-Founder, CEO and Chairman of Gossamer Bio. Laura Carter is our Chief Scientific Officer. Laura has 20 years of industry experience spanning target identification and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |